Compugen Ltd.
Market Cap
$214.64M
P/E Ratio
5.97
EPS
$0.38
Dividend Yield
0.00%
52-Week Range
$1.13 — $2.38
Volume
174.42K
Avg Volume
394.05K
Beta
2.96
P/E (TTM)
5.97
Forward P/E
—
PEG Ratio
0.03
P/S (TTM)
2.87
P/B (TTM)
2.03
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.56%
ROA (TTM)
0.23%
ROIC
—
Gross Margin
0.87%
Operating Margin
0.43%
Net Margin
—
Debt/Equity
0.03
Current Ratio
6.56
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.25%
EPS Growth (5Y)
+0.16%
Sales Growth (3Y)
+1.18%
Sales Growth (5Y)
+1.11%
EPS Est (This Year)
$-0.21
EPS Est (Next Year)
$-0.15
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.54
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
93.54M
Float
91.64M
Free Float %
97.97%
Sector
Healthcare
Industry
Biotechnology
Country
IL
Exchange
NASDAQ
IPO Date
2000-08-11
Employees
74
CEO
Eran Ophir
Index Membership
—
Website
https://cgen.com
Compugen Ltd. (CGEN) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $214.64M, a P/E ratio of 5.97, CGEN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare CGEN against other stocks using dozens of fundamental and technical filters.
Compugen Ltd. (CGEN) has a trailing twelve-month (TTM) P/E ratio of 5.97. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Compugen Ltd. (CGEN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Compugen Ltd. (CGEN) has a market capitalization of $214.64 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.